Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Managing erectile dysfunction in hypertensive patients.

Handler J.

J Clin Hypertens (Greenwich). 2011 Jun;13(6):450-4. doi: 10.1111/j.1751-7176.2011.00465.x. Epub 2011 Apr 22. No abstract available.

2.

Aliskiren/hydrochlorothiazide (Tekturna HCT) for hypertension.

[No authors listed]

Med Lett Drugs Ther. 2008 Aug 25;50(1293):65-6. No abstract available.

PMID:
18719523
3.

[Young patient with mild hypertension: angiotensin inhibitor or beta blocker?].

Girndt M.

MMW Fortschr Med. 2011 Sep 22;153(38):17. German. No abstract available.

PMID:
21977791
4.

Combination therapy with various combinations of aliskiren, valsartan, and hydrochlorothiazide in hypertensive patients not adequately responsive to hydrochlorothiazide alone.

Geiger H, Barranco E, Gorostidi M, Taylor A, Zhang X, Xiang Z, Zhang J.

J Clin Hypertens (Greenwich). 2009 Jun;11(6):324-32. doi: 10.1111/j.1751-7176.2009.00114.x.

5.

Aliskiren alone or in combination with hydrochlorothiazide in patients with the lower ranges of stage 2 hypertension: The ACQUIRE randomized double-blind study.

Black HR, Kribben A, Aguirre Palacios F, Bijarnia M, Laflamme AK, Baschiera F.

J Clin Hypertens (Greenwich). 2010 Dec;12(12):917-26. doi: 10.1111/j.1751-7176.2010.00378.x. Epub 2010 Oct 4.

6.
7.

A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome.

Racine N, Hamet P, Sampalis JS, Longo N, Bastien N.

J Hum Hypertens. 2010 Nov;24(11):739-48. doi: 10.1038/jhh.2010.3. Epub 2010 Feb 11.

PMID:
20147971
9.

Clinical inquiry: How do hydrochlorothiazide and chlorthalidone compare for treating hypertension?

Kildare L, Jones T, Neher JO, St Anna L.

J Fam Pract. 2014 Apr;63(4):227-8. Review. No abstract available.

PMID:
24905126
10.

Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis.

Van Bortel LM, Fici F, Mascagni F.

Am J Cardiovasc Drugs. 2008;8(1):35-44.

PMID:
18303936
11.

Aliskiren combined with losartan in type 2 diabetes and nephropathy.

Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK; AVOID Study Investigators..

N Engl J Med. 2008 Jun 5;358(23):2433-46. doi: 10.1056/NEJMoa0708379.

12.

Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.

Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH.

Clin Exp Pharmacol Physiol. 2007 Apr;34(4):327-31.

PMID:
17324145
13.

[Experience of the use of nebivolol in the treatment of hypertension in postmenopausal women].

Bart BIa, Benevskaia VF, Buval'tsev VI, Boronenkov GM.

Kardiologiia. 2002;42(8):20-4. Russian.

PMID:
12494089
14.

Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial.

Ferdinand KC, Pool J, Weitzman R, Purkayastha D, Townsend R.

J Clin Hypertens (Greenwich). 2011 May;13(5):366-75. doi: 10.1111/j.1751-7176.2010.00416.x. Epub 2011 Jan 18.

15.

Aliskiren for hypertension: just another option or something truly unique?

Lee S.

S D Med. 2007 Oct;60(10):405-6. Review. No abstract available.

PMID:
18019776
16.

Aliskiren (Tekturna) a new weapon to battle the silent killer.

Laustsen G.

Nurse Pract. 2007 Jul;32(7):6-7. No abstract available.

PMID:
17595578
17.

Sleep quality in patients with hypertension: additional negative effect of drug therapy.

Yontar OC, Erdem A, Yilmaz MB.

Sleep Med. 2009 Dec;10(10):1168; author reply 1168-9. doi: 10.1016/j.sleep.2009.04.001. Epub 2009 May 20. No abstract available.

PMID:
19467925
19.

Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.

Pool JL, Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A.

Am J Hypertens. 2007 Jan;20(1):11-20.

PMID:
17198906
20.

Impact of losartan on stroke risk in hypertensive patients in primary care.

Bestehorn K, Wahle K.

Clin Drug Investig. 2007;27(5):347-55.

PMID:
17451283

Supplemental Content

Support Center